Cargando…

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting

Detalles Bibliográficos
Autores principales: Ayers, LW, Ogwang, M, Zhou, W, Mbulaiteye, SM, Bhatia, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261845/
http://dx.doi.org/10.1186/1750-9378-4-S2-P6
_version_ 1782348342180708352
author Ayers, LW
Ogwang, M
Zhou, W
Mbulaiteye, SM
Bhatia, K
author_facet Ayers, LW
Ogwang, M
Zhou, W
Mbulaiteye, SM
Bhatia, K
author_sort Ayers, LW
collection PubMed
description
format Online
Article
Text
id pubmed-4261845
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42618452014-12-10 Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting Ayers, LW Ogwang, M Zhou, W Mbulaiteye, SM Bhatia, K Infect Agent Cancer Poster Presentation BioMed Central 2009-06-17 /pmc/articles/PMC4261845/ http://dx.doi.org/10.1186/1750-9378-4-S2-P6 Text en Copyright © 2009 Ayers et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Ayers, LW
Ogwang, M
Zhou, W
Mbulaiteye, SM
Bhatia, K
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title_full Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title_fullStr Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title_full_unstemmed Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title_short Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
title_sort value of cd44 immunostaining (ihc) as a surrogate in the differentiation of myc-positive burkitt lymphoma (bl) and burkitt lymphoma-like (bll) from myc-negative diffuse large b-cell lymphoma (dlbcl) in a resource constrained clinical setting
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261845/
http://dx.doi.org/10.1186/1750-9378-4-S2-P6
work_keys_str_mv AT ayerslw valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting
AT ogwangm valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting
AT zhouw valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting
AT mbulaiteyesm valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting
AT bhatiak valueofcd44immunostainingihcasasurrogateinthedifferentiationofmycpositiveburkittlymphomablandburkittlymphomalikebllfrommycnegativediffuselargebcelllymphomadlbclinaresourceconstrainedclinicalsetting